Anish Suri
2020
In 2020, Anish Suri earned a total compensation of $2.1M as President and Chief Scientific Officer at Cue Biopharma, a 53% decrease compared to previous year.
Compensation breakdown
| Bonus | $159,600 |
|---|---|
| Option Awards | $835,478 |
| Salary | $420,000 |
| Stock Awards | $709,500 |
| Other | $4,092 |
| Total | $2,128,670 |
Suri received $835.5K in option awards, accounting for 39% of the total pay in 2020.
Suri also received $159.6K in bonus, $420K in salary, $709.5K in stock awards and $4.1K in other compensation.
Rankings
In 2020, Anish Suri's compensation ranked 5,238th out of 13,090 executives tracked by ExecPay. In other words, Suri earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,238 out of 13,090 | 60th |
Division Manufacturing | 2,158 out of 5,621 | 62nd |
Major group Chemicals And Allied Products | 862 out of 2,254 | 62nd |
Industry group Drugs | 741 out of 1,954 | 62nd |
Industry Pharmaceutical Preparations | 555 out of 1,459 | 62nd |
Source: SEC filing on April 26, 2021.
Suri's colleagues
We found two more compensation records of executives who worked with Anish Suri at Cue Biopharma in 2020.